Figure 8
From: Metabolic system alterations in pancreatic cancer patient serum: potential for early detection
Decision curve analysis (DCA) for prediction of PC based on PC-594. The plot compares the net clinical benefits of four scenarios: a perfect prediction model (grey dashed line), screen none (solid horizontal black line), screen everyone with EUS (grey line), and screen based on the PC-594 model. Data for the plot was based on the USA2 validation cohort (PC prevalence of 26%). See Results for further explanation.